The pregnant women living with hiv antiretroviral therapy coverage for pmtct in the Gambia currently stands at 59%, indicating a decrease of 2% (-3.3%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in the Gambia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for the Gambia
Gambia PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 59% | -2% |
| 2021 | 61% | +16% |
| 2020 | 45% | -2% |
| 2019 | 47% | -4% |
| 2018 | 51% | -1% |
| 2017 | 52% | 0% |
| 2016 | 52% | -8% |
| 2015 | 60% | +11% |
| 2014 | 49% | 0% |
| 2013 | 49% | +2% |
| 2012 | 47% | -9% |
| 2011 | 56% | +14% |
| 2010 | 42% | -2% |
| 2009 | 44% | +17% |
| 2008 | 27% | +17% |
| 2007 | 10% | +2% |
| 2006 | 8% | +1% |
| 2005 | 7% | +7% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |